123 Discussion of toxicity and biomarkers in a phase i trial of gefitinib (IRESSATM) in combination with radiation or chemo-radiation for patients with locally advanced head and neck cancer (LAHNC)

Authors :: H. Quon
J. Dancey
David Raben
Madeleine A. Kane
Changhu Chen
Kenneth S. Hu
K. McCoy
A. Meyers
J. Song
G.S. Eckhardt
Adam Raben
Source :: Radiotherapy and Oncology. 78:S39
Publication Year :: 2006
Publisher :: Elsevier BV, 2006.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Head and neck cancer
Locally advanced
Hematology
medicine.disease
Chemo radiation
Gefitinib
Internal medicine
Toxicity
medicine
Radiology, Nuclear Medicine and imaging
business
medicine.drug

Tools